NCTWX
Price
$36.59
Change
-$0.23 (-0.62%)
Updated
Dec 17 closing price
PMAQX
Price
$46.25
Change
-$0.48 (-1.03%)
Updated
Dec 17 closing price
Ad is loading...

NCTWX vs PMAQX

Header iconNCTWX vs PMAQX Comparison
Open Charts NCTWX vs PMAQXBanner chart's image
Nicholas II I
Price$36.59
Change-$0.23 (-0.62%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$46.25
Change-$0.48 (-1.03%)
VolumeN/A
CapitalizationN/A
NCTWX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NCTWX vs. PMAQX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCTWX is a Hold and PMAQX is a Hold.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.7B vs. NCTWX (1.16B). NCTWX pays higher dividends than PMAQX: NCTWX (0.32) vs PMAQX (0.10). NCTWX was incepted earlier than PMAQX: NCTWX (41 years) vs PMAQX (8 years). PMAQX is a more actively managed with annual turnover of: 10.10 vs. NCTWX (6.26). PMAQX has a lower initial minimum investment than NCTWX: PMAQX (0) vs NCTWX (100000). PMAQX annual gain was more profitable for investors over the last year : 21.78 vs. NCTWX (12.53). PMAQX return over 5 years is better than : 50.76 vs. NCTWX (17.91).
NCTWXPMAQXNCTWX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence41 years8 years-
Gain YTD11.62320.63156%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.16B29.7B4%
Annual Yield % from dividends0.320.10324%
Returns for 1 year12.5321.7858%
Returns for 3 years-0.1215.44-1%
Returns for 5 years17.9150.7635%
Returns for 10 years27.34N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COUR8.850.13
+1.49%
Coursera
MHH13.73-0.02
-0.15%
Mastech Digital
BSAC19.07-0.26
-1.35%
Banco Santander-Chile
TRST36.19-1.61
-4.26%
TrustCo Bank Corp
PHIO2.70-0.14
-4.93%
Phio Pharmaceuticals Corp